miRNA-Based Therapeutics in the Era of Immune-Checkpoint Inhibitors. Posted bybrigittemeiswinkel 26. May 2021 Huemer, F; Leisch, M; Geisberger, R; Zaborsky, N; Greil, R. Pharmaceuticals (Basel). 2021 Jan 26;14(2):89. doi: 10.3390/ph14020089.